Upgrade to SI Premium - Free Trial

Morgan Stanley Downgrades Allergen (AGN) to Equalweight

January 30, 2019 5:06 AM
Morgan Stanley analyst David Risinger downgraded Allergen (NYSE: AGN) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change Downgrades

Next Articles